Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06355895 · ClinicalTrials.gov registry record · NA
Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies
A NA study of Upper Abdominal Malignancies, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT06355895: Recruiting NA study of Upper Abdominal Malignancies, sponsored by University of Pittsburgh.
NCT06355895 is a NA study of Upper Abdominal Malignancies that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06355895, a NA study of Upper Abdominal Malignancies, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
Standard planning constraints for liver SBRT incorporate strict dose-volume limits for normal liver parenchyma to minimize the risk of radiation-induced liver disease. The presence of diurnal and fasting/fed variations in liver volume therefore carry substantial potential for introducing errors into estimates of dose-volume distribution within normal liver tissue, as well as affecting day-to-day setup fidelity and organ alignment for treatment. This prospective study will examine how diurnal and fast-fed variations in liver volume affect treatment planning for abdominal SBRT.
Primary Outcome
Percentage diurnal difference in total liver volumes (change in liver volume), as measured by Stereotactic Body Radiation Therapy (SBRT) planning software.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Standardized high-carbohydrate meal
Study Locations (1)
Pennsylvania
- UPMC Hillman Cancer Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2024-05-16 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT06355895 shows while recruiting
NCT06355895 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Upper Abdominal Malignancies appearing as the primary indexed condition, and to 1 intervention - of which Standardized high-carbohydrate meal is the first listed.
NCT06355895 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06355895 about?
NCT06355895 is a clinical study titled "Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies". Standard planning constraints for liver SBRT incorporate strict dose-volume limits for normal liver parenchyma to minimize the risk of radiation-induced liver disease. The presence of diurnal and fasting/fed variations in liver volume therefore carry substantial potential for introducing errors into...
What is the current status of trial NCT06355895?
This trial is currently recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2024-05-16. Estimated completion is 2026-03-31.
What conditions does trial NCT06355895 study?
This clinical trial studies the following conditions: Upper Abdominal Malignancies.
What interventions are being tested in trial NCT06355895?
The interventions under investigation include: Standardized high-carbohydrate meal (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06355895?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06355895 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06355895's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI